BriaCell Therapeutics Corp Warrant
BCTXZ
3 hedge funds and large institutions have $1.21M invested in BriaCell Therapeutics Corp Warrant in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
49.42% more ownership
Funds ownership: 0% → 49.42% (+49%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$646K |
| 2 |
HCM
Heights Capital Management
San Francisco,
California
|
+$596K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.28K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $635K | +$646K | +598,743 | New |
|
|
HCM
2
Heights Capital Management
San Francisco,
California
| $574K | +$596K | +552,081 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $1.26K | +$1.28K | +1,189 | New |
|
BCTXZ Hedge Fund Activity: Q2 2025 in Review
3 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXZ) for Q2 2025, worth a combined $1.21M.
Buyers outnumbered sellers: 3 funds opened new BCTXZ positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $646K.
- 3 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXZ) as of Q2 2025, up from 0 in Q1 2025.
- Funds reported $1.21M of BriaCell Therapeutics Corp Warrant stock for Q2 2025.
- 3 funds opened new BriaCell Therapeutics Corp Warrant positions in Q2 2025 and 0 closed out, a net change of +3 holders.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q2 2025 was Sabby Management, an estimated $646K added.
Based on aggregated 13F filings for Q2 2025.